发明名称 |
Variant, Recombinant Beta-Glucocerebrosidase Proteins With Increased Stability And Increased Retained Catalytic Activity |
摘要 |
Described herein are variant, recombinant β-glucocerebrosidase proteins characterized as having increased stability relative to recombinant wild-type β-glucocerebrosidase. Also provided herein are variant, recombinant β-glucocerebrosidase proteins characterized as retaining more catalytic activity relative to recombinant wild-type β-glucocerebrosidase. Further described herein are variant, recombinant β-glucocerebrosidase proteins that can have amino acid variations at one or more of the following positions: 316, 317, 321 and 145. Methods of making the variant, recombinant β-glucocerebrosidase proteins are also described as well as methods of treating patients having lysosomal storage diseases. |
申请公布号 |
US2015216950(A1) |
申请公布日期 |
2015.08.06 |
申请号 |
US201514611495 |
申请日期 |
2015.02.02 |
申请人 |
Amicus Therapeutics, Inc. |
发明人 |
Do Hung V. |
分类号 |
A61K38/47;C12N9/24 |
主分类号 |
A61K38/47 |
代理机构 |
|
代理人 |
|
主权项 |
1. A variant, recombinant human β-glucocerebrosidase protein, wherein the protein has at least one of the following substitutions relative to SEQ ID NO: 1: F316A, L317F, K321V, K321A, H145L and H145F. |
地址 |
Cranbury NJ US |